Procurement of Pharmaceuticals and Rdts

PakistanTenders notice for Procurement of Pharmaceuticals and Rdts. The reference ID of the tender is 77795801 and it is closing on 13 Feb 2023.

100% Secure Payments

Tender Details

  • Country: Pakistan
  • Summary: Procurement of Pharmaceuticals and Rdts
  • PKT Ref No: 77795801
  • Deadline: 13 Feb 2023
  • Competition: ICB
  • Financier: World Bank (WB)
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: PK-PSHD-336444-GO-RFB
  • Purchaser's Detail :
  • Purchaser : PRIMARY AND SECONDARY HEALTH DEPARTMENT
    Directorate of IRMNCH & NP, 05-Montgomery Road, Lahore.
    Province/State : Pakistan
    Country : Pakistan
    Name : Akhtar Rasheed
    Phone : 03328452830
    Email :akhtardoc@gmail.com

  • Description :
  • Procurement of Pharmaceuticals and RDTs
    Notice Type : Invitation for Bids
    Project Title : Punjab Human Capital Investment Project - P164785
    Notice No : OP00210509
    Language of Notice : English
    Published Date : January 23, 2023
    Submission Deadline Date/Time : Feb 13, 2023 12:00
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
PakistanTenders Features

PakistanTenders Features

Fresh and verified Tenders from Pakistan. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Pakistan in your email inbox.

  Chat with us